Navaneet Chaturvedi

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Neoadjuvant Chemotherapy

Men Who Have Sex With Men

Drug Administration

Top Venues

Molecules (Basel, Switzerland)

University of Leicester

University of Allahabad (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Leicester Feb 27 2020

United Kingdom

PostDoc

University of Information Science and Technology St. Paul The Apostle Apr 06 2019 - Jan 11 2020

North Macedonia

Assistant Professor

Indian Institute of Technology BHU Feb 05 2018 - Feb 20 2019

India

Researcher :: School of Biochemical Engineering

Tel Aviv University Nov 29 2013 - Sep 30 2017

Israel

Post-Doc :: Biochemistry and Molecular Biology

Education History

University of Allahabad Aug 10 2006 - Jul 31 2008

India

MSC :: Center of Bioinformatics

Publications

Anandakrishnan Karthic, Veerbhan Kesarwani, Rahul Kunwar Singh, Pavan Kumar Yadav, Navaneet Chaturvedi, Pallavi Chauhan, Brijesh Singh Yadav, Sandeep Kumar Kushwaha
Computational Analysis Reveals Monomethylated Triazolopyrimidine as a Novel Inhibitor of SARS-CoV-2 RNA-Dependent RNA Polymerase (RdRp). Molecules (Basel, Switzerland) 27 (3) (2022)
Mutaib M Mashraqi, Navaneet Chaturvedi, Qamre Alam, Saleh Alshamrani, Mosa M Bahnass, Khursheed Ahmad, Amany I Alqosaibi, Mashael M Alnamshan, Syed Sayeed Ahmad, Mirza Masroor Ali Beg, Abha Mishra, Sibhghatulla Shaikh, Syed Mohd Danish Rizvi
Biocomputational Prediction Approach Targeting FimH by Natural SGLT2 Inhibitors: A Possible Way to Overcome the Uropathogenic Effect of SGLT2 Inhibitor Drugs. Molecules (Basel, Switzerland) 26 (3) (2021)
Khursheed Ahmad, Vishal M Balaramnavar, Navaneet Chaturvedi, Saif Khan, Shafiul Haque, Yong-Ho Lee, Inho Choi
Targeting Caspase 8: Using Structural and Ligand-Based Approaches to Identify Potential Leads for the Treatment of Multi-Neurodegenerative Diseases. Molecules (Basel, Switzerland) 24 (9) (2019)